Issue link: http://deals.uberflip.com/i/1489093
OB-GYN & Aesthetic Practice Located in Southern US #65972 Sign NDA ► 2022 Revenue Est. $3,500,000 2022 Ebitda Est. $741,000 2022 Cash Flow Est. $1,041,000 DISCLAIMER: All information contained in this document has been provided by the subject company to Generational Equity and while believed to be correct has not been verified. Accordingly, Generational Equity makes no representations or warranties as to the accuracy and truthfulness of such information. The recipient hereof acknowledges that Generational Equity shall not be liable for any loss or injury suffered by said recipient in any way connected to the delivery by Generational Equity of this document. At all times Generational Equity and its affiliate network members is an agent for the seller and not for the buyer. Generational Equity's fees are paid by the seller. Lane Carrick Senior M&A Advisor lcarrick@generational.com Office: 469-828-2841 Generational Group 3400 N. Central Expressway, Ste. 100 Richardson, TX 75080 Fax: 972-392-8564 BUSINESS HIGHLIGHTS The Company is a leading provider gynecology, obstetrics, and women's imaging services. With their other locations also providing dermal fillers, skin tightening, weight loss shots, & much more. The company works with almost all leading insurance providers. Having a strong loyalty commitment from their clients, the company maintains a 75% rate of repeat business. The Company is supported by 15 F/T professionals, including 3 medical personnel and 3 nursing staff. INVESTMENT BANK OF THE YEAR 2016 - 2017 - 2018 COMPANY STATS Over 30 yrs of operations Highly profitable 15 FT Employees INVESTMENT APPEAL • Management Will Remain through Transition - Ownership is interested and willing to remain with the Company after a transaction to facilitate an orderly transition to new ownership and, as appropriate, assist in achieving long-term strategic growth objectives. • Facilities Will Support Pro Forma Growth– The Company facilities and resources are not currently at capacity, so future growth will be supported by the current assets and facilities on hand. The Company can increase revenue by bringing in additional medical professionals to increase customer volume. • Highly Profitable Niche Business - Over the historical period, the Company's EBITDA margin averaged 11.9%, and ranged from 4.7% to 19.5%. Management notes that the COVID-19 pandemic weighed on margins, and typically achieves an EBITDA margin well above average. GROWTH OPPORTUNITY Facility Expansion Additional Locations Market Expansion Average Settlement